Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta-analysis

16Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This systematic review and meta-analysis sought to summarize the available evidence on the use of transcatheter aortic valve replacement (TAVR) in patients with Native Aortic Valve Regurgitation (NAVR) and compare outcomes between first and second generation valves. Owing to the improvements in transcatheter heart valve design and procedural success, TAVR has become increasingly performed in broader aortic valve pathologies. We searched Medline, Embase, Cochrane, and Scopus databases from 2007 to 2018 and performed a systematic review on reports with at least 10 patients with aortic valve regurgitation undergoing TAVR procedure. The main outcome of interest was all-cause mortality at 30 days. A total of 638 patients across 12 studies were included. Mean age ranged from 68 to 84. Society of Thoracic Surgeons score ranged from 5.4% to 13.1% and Logistic EuroSCORE ranged from 18.2% to 33%. The incidence rate of all-cause mortality at 30 days was found to be 11% (95% CI 7%-16%; I 2 = 20.86%). All-cause mortality at 30 days for first generation valves had an incidence rate of 15% (95% CI 10%-20%; I 2 = 10%) compared to 7% (95% CI 3%-13%; I 2 = 37%) in second generation valves with subgroup interaction analysis P = 0.059. Device success incidence rate in second generation valves was 92% (95% CI 83%-99%; I 2 = 67%) vs 68% (95% CI 59%-77%; I 2 = 53%) in first generation valves with P = 0.001. TAVR appears to be a feasible treatment choice for NAVR patients at high risk for surgical valve replacement. Second generation valves show promising results in terms of short-term outcomes.

References Powered by Scopus

Measuring inconsistency in meta-analyses

48709Citations
N/AReaders
Get full text

Meta-analysis in clinical trials

32748Citations
N/AReaders
Get full text

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

25719Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Predictors of permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement-a systematic review and meta-analysis

42Citations
N/AReaders
Get full text

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study

32Citations
N/AReaders
Get full text

Pathophysiology and management of combined aortic and mitral regurgitation

16Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Haddad, A., Arwani, R., Altayar, O., Sawas, T., Murad, M. H., & de Marchena, E. (2019, January 1). Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta-analysis. Clinical Cardiology. John Wiley and Sons Inc. https://doi.org/10.1002/clc.23103

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

57%

Researcher 6

43%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

83%

Biochemistry, Genetics and Molecular Bi... 1

6%

Business, Management and Accounting 1

6%

Pharmacology, Toxicology and Pharmaceut... 1

6%

Article Metrics

Tooltip
Mentions
News Mentions: 3

Save time finding and organizing research with Mendeley

Sign up for free